Siremadlin
N/A
Report date: 2026/05/13 20:02:10
NME
Base Information
Drug NameSiremadlin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[25]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesNovartis Pharma Ag
Inactive CompaniesNovartis Pharma Schweiz AgNovartis Pharma Stein AgChina Novartis Institutes For Biomedical Research Co Ltd
Active Indications +[6]
Inactive Indications +[8]
Other Information
ATC CodeN/A
Related LinksN/A